Suchergebnisse - "Komatsu, Motoaki"

PubPharm (40)

1

Cellular and humoral immune responses to COVID-19 booster vaccination in Japanese dialysis patients

enthalten in: Clinical and experimental nephrology | 2024

von Yoshifuji, A. | Toda, M. | Oyama, E. | +19

2

Negative conversion of T-SPOT results after hemodialysis: case series and literature review

enthalten in: Renal replacement therapy | 2023

von Toda, M. | Yoshifuji, A. | Hosoya, K. | +3

3

Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis

enthalten in: Vaccines | 2023

von Toda, M. | Yoshifuji, A. | Nakayama, T. | +9

4

Ultra-Low-Dose Contrast Using Transluminal Renal Angioplasty : The ULTRA Study

enthalten in: Vascular and endovascular surgery | 2023

von Kawano, M. | Suzuki, K. | Fujimura, N. | +7

5

Chryseobacterium indologenes Peritonitis in a Peritoneal Dialysis Patient : A Case Report and Review of Literature

enthalten in: Case reports in nephrology and dialysis | 2023

von Miyakawa, A. | Fujii, K. | Kato, A. | +4

6

Ceftazidime encephalopathy developed without the elevation of cerebrospinal fluid concentration of ceftazidime : A case report of two cases

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2022

von Toda, M. | Yoshifuji, A. | Hosoya, K. | +8

7

A case of Bacillus subtilis var. natto bacteremia caused by ingestion of natto during COVID-19 treatment in a maintenance hemodialysis patient with multiple myeloma

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2022

von Kato, A. | Yoshifuji, A. | Komori, K. | +8

8

Correction to : Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients

enthalten in: Clinical and experimental nephrology | 2022

von Toda, M. | Yoshifuji, A. | Kikuchi, K. | +7

ErratumFor: Clin Exp Nephrol. 2022 Jun;26(6):571-580. - PMID 35133533

9

Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients

enthalten in: Clinical and experimental nephrology | 2022

von Toda, M. | Yoshifuji, A. | Kikuchi, K. | +7

ErratumIn: Clin Exp Nephrol. 2022 Mar 9;:. - PMID 35262832

10

Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19

enthalten in: Renal replacement therapy | 2022

von Toda, M. | Yoshifuji, A. | Fujii, K. | +5